The role of the community in engaging on vaccination issues is essential

GSK and ViiV Healthcare aim to ‘pull back the curtain’ on the PBS with a video and report that explain how the Government assesses new medicines and vaccines.

GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.

Immunisation rates among Australian children has risen significantly over the years. However, there remains a distinct disparity between children from Aboriginal and Torres Strait Islander communities and other Australians.

Back to top